Cell-free nucleic acids as biomarkers in dialyzed patients

Journal of Nephrology

Volumn 26, Issue 6, 2013, Pages 1001-1008

  Korabecna, Marie ^a   Pazourkova, Eva ^a   Horinek, Ales ^a   Rocinova, Katerina ^a   Tesar, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cell free DNA; Cell free nucleic acids; Hemodialysis; Immune response; Mirna; Peritoneal dialysis

Indexed keywords

BIOLOGICAL MARKER; CELL FREE NUCLEIC ACID; UNCLASSIFIED DRUG; DNA; MESSENGER RNA; MICRORNA; NUCLEIC ACID;

BIOINFORMATICS; CIRCULATION; COMORBIDITY; DIALYSIS MEMBRANE; FUNCTIONAL STATUS; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; KIDNEY CLEARANCE; KIDNEY FAILURE; MOLECULAR INTERACTION; NUCLEIC ACID ANALYSIS; PERITONEAL DIALYSIS; PROGNOSIS; REVIEW; APOPTOSIS; BLOOD; GENETICS; KIDNEY FAILURE, CHRONIC; NECROSIS; RENAL REPLACEMENT THERAPY;

APOPTOSIS; BIOLOGICAL MARKERS; COMORBIDITY; DNA; HUMANS; KIDNEY FAILURE, CHRONIC; MICRORNAS; NECROSIS; NUCLEIC ACIDS; PERITONEAL DIALYSIS; RENAL DIALYSIS; RNA, MESSENGER;

EID: 84889676353     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000301     Document Type: Review

References (54)

1. Mandel P, Metais P. Les acides nucléiques du plasma sanguine chez l'homme. C R Seances Soc Biol Fil. 1948;142(3-4):241-243.
2. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007;5(5):795-799.
3. Ayala W, Moore LV, Hess EL. The purple color reaction given by diphenylamine reagent. I. With normal and rheumatic fever sera. J Clin Invest. 1951;30(7):781-785.
4. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37(3):646-650.
5. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev. 1994;3(1):67-71.
6. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):350-487.
7. Peters DL, Pretorius PJ. Origin, translocation and destination of extracellular occurring DNA a new paradigm in genetic behaviour. Clin Chim Acta. 2011;412(11-12):806-811.
8. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta. 2001;313(1-2):139-142.
9. Anker P, Stroun M, Maurice PA. Spontaneous extracellular synthesis of DNA released by human blood lymphocytes. Cancer Res. 1976;36(8):2832-2839.
10. Beck J, Urnovitz HB, Riggert J, Clerici M, Schütz E. Profile of the circulating DNA in apparently healthy individuals. Clin Chem. 2009;55(4):730-738.
11. Taylor DD, Zacharias W, Gercel-Taylor C. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol. 2011;728:235-246.
12. Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics. 2008;8(19): 4083-4099.
13. Koyama S, Akira S, Ishii KJ. Immune recognition of nucleic acids and their metabolites. In: Rykova EY, Kikuchi Y, eds. Extracellular nucleic acids. 1st ed. Berlin, Germany: Springer; 2010.
14. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64(1):218-224.
15. Cherepanova AV, Tamkovich SN, Bryzgunova OE, Vlassov VV, Laktionov PP. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors. Ann N Y Acad Sci. 2008;1137(1):218-221.
16. Holdenrieder S, Stieber P, Bodenmüller H, et al. Circulating nucleosomes in serum. Ann N Y Acad Sci. 2001;945(1): 93-102.
17. Burlingame RW, Volzer MA, Harris J, Du Clos TW. The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice. J Immunol. 1996;156(12): 4783-4788.
18. Gauthier VJ, Tyler LN, Mannik M. Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol. 1996;156(3):1151-1156.
19. Kobayashi N, Kuramoto T, Yamaoka K, Hashida M, Takakura Y. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J Pharmacol Exp Ther. 2001;297(3):853-860.
20. Botezatu I, Serdyuk O, Potapova G, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem. 2000;46(8 Pt 1):1078-1084.
21. Chan KC, Leung SF, Yeung SW, Chan ATC, Lo YMD. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients. Clin Cancer Res. 2008;1(15):4809-4813.
22. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M, Mueller MM. Cell-free plasma DNA: a marker for apoptosis during hemodialysis. Clin Chem. 2006;52(3):523-526.
23. García Moreira V, de la Cera Martínez T, Gago González E, Prieto García B, Alvarez Menéndez FV. Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR. Clin Chem Lab Med. 2006;44(12):1410-1415.
24. Korabecna M, Opatrna S, Wirth J, et al. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann N Y Acad Sci. 2008;1137(1):296-301.
25. Horinek A, Panczak A, Mokrejsova M, et al. Comparison of plasma cell-free DNA levels with gene expression profiles of peripheral blood cells during hemodialysis. In: Gahan P, ed. Circulating nucleic acids in plasma and serum. Berlin, Germany: Springer; 2011:159-163.
26. Fatouros IG, Destouni A, Margonis K, et al. Cell-free plasma DNA as a novel marker of aseptic inflammation severity related to exercise overtraining. Clin Chem. 2006;52(9): 1820-1824.
27. Atamaniuk J, Vidotto C, Tschan H, et al. Increased concentrations of cell-free plasma DNA after exhaustive exercise. Clin Chem. 2004;50(9):523-526.
28. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000;46(3):319-323.
29. Rainer TH, Lam NYL. Circulating nucleic acids and critical illness. Ann N Y Acad Sci. 2006;1075(1):271-277.
30. Antonatos D, Patsilinakos S, Spanodimos S, Korkonikitas P, Tsigas D. Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann N Y Acad Sci. 2006;1075(1): 278-281.
31. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006;10(2):R60.
32. Saukkonen K, Lakkisto P, Varpula M, et al. Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med. 2007;33(9):1624-1627.
33. García Moreira V, Prieto García B, Baltar Martín JM, Ortega Suárez F, Alvarez FV. Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Clin Chem. 2009;55(11):1958-1966.
34. Vlassov VV, Laktionov PP, Rykova EY. Circulating nucleic acids as a potential source for cancer biomarkers. Curr Mol Med. 2010;10(2):142-165.
35. Carracedo J, Ramirez R, Pintado O, et al. Cell aggregation and apoptosis induced by hemodialysis membranes. J Am Soc Nephrol. 1995;9:1586-1591.
36. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80(8): 2012-2020.
37. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol. 1993;54(4):283-288.
38. Steinman CR, Ackad A. Appearance of circulating DNA during hemodialysis. Am J Med. 1977;62(5):693-697.
39. Fournié GJ, Lulé J, Dueymes JM, et al. Plasma DNA in patients undergoing hemodialysis or hemofiltration: cytolysis in artificial kidney is responsible for the release of DNA in circulation. Am J Nephrol. 1989;9(5):384-391.
40. Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR. Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol. 1992;90(1):56-62.
41. Tovbin D, Novack V, Wiessman MP, Elkadir AA, Zlotnik M, Douvdevani A. Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant. 2012;10(10):3929-3935.
42. Atamaniuk J, Kopecky C, Skoupy S, Saemann MD, Weichhart T. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant. 2012;3(3): 902-905.
43. Korabecna M, Pazourkova E, Horinek A, Mokrejsova M, Tesar V. Alterations in methylation status of immune response genes promoters in cell-free DNA during a hemodialysis procedure. Expert Opin Biol Ther. 2012;12(S1)(Suppl 1):S27-S33.
44. Martino F, Lorenzen J, Schmidt J, et al. Circulating microRNAs are not eliminated by hemodialysis. PLoS ONE. 2012;7(6):e38269.
45. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39(16):7223-7233.
46. Gupta SK, Bang C, Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet. 2010;3(5): 484-488.
47. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res. 2012;93(4):555-562.
48. Lorenzen JM, Kielstein JT, Hafer C, et al. Circulating miR 210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2011;6(7):1540-1546.
49. Emilian C, Goretti E, Prospert F, et al. MicroRNAs in patients on chronic hemodialysis (MINOS study). Clin J Am Soc Nephrol. 2012;7(4):619-623.
50. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-10518.
51. Wang H, Peng W, Ouyang X, Dai Y. Reduced circulating miR- 15b is correlated with phosphate metabolism in patients with end-stage renal disease on maintenance hemodialysis. Ren Fail. 2012;34(6):685-690.
52. Ozkaya O, Bek K, Bedir A, Açikgöz Y, Ozdemir T. Plasma cell- free DNA levels in children on peritoneal dialysis. Nephron Clin Pract. 2009;113(4):c258-c261.
53. Pajek J, Kveder R, Gucek A, et al. Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions. Ther Apher Dial. 2010;14(1):20-26.
54. Chen J, Kam-Tao P, Kwan BC, et al. Relation between microRNA expression in peritoneal dialysis effluent and peritoneal transport characteristics. Dis Markers. 2012;33(1):35-42.